TE_49

Basic information Differential Expression Stage analysis Survival analysis Correlation analysis

TE family MIR3
TE superfamily L2-end
TE class SINE
Gene ENSG00000289893
Class Chimeric
Coding Non-coding
Tumor-specific score 3.18
Counts of samples TCGA_tumor:30; TCGA_normal:0; GTEx:10
TSS chr1(-):5773732



Transcript isoforms

Transcript_ID Gene Class Coding ORF Position
teRNA_49.1 ENSG00000289893 Chimeric Non-coding Non-coding chr1(-):5734533,5734553,5744376,5744491,5752238,5752315,5771360,5771524,5773653,5773733
teRNA_49.2 ENSG00000289893 Chimeric Non-coding Non-coding chr1(-):5734533,5734553,5744376,5744491,5752238,5752315,5771360,5771524,5771800,5771996,5773653,5773733
teRNA_49.3 ENSG00000289893 Chimeric Non-coding Non-coding chr1(-):5734533,5734553,5744376,5744491,5752238,5752315,5771360,5771521,5771800,5771996,5773653,5773733
teRNA_49.4 ENSG00000289893 Chimeric Non-coding Non-coding chr1(-):5734533,5734553,5744376,5744491,5752238,5752315,5771360,5771996,5773653,5773733


GTEx

The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.




TCGA

The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).




GTEx

The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.




TCGA

The expression of TE-initiated transcript across 33 cancer types from The Cancer Genome Atlas (TCGA).